{"id": "cnbbll", "title": "Coherus Biosciences", "selftext": "Does anyone follow Coherus Biosciences (NADAQ: CHRS)? If so, can anyone offer a compelling reason why the stock isn't priced closer to analyst price targets (currently trading around $19; analyst recommendations of $29)? Based on their earnings and most recent guidance, I would think they would be even higher than analyst recommendations (novice assessment). Just trying to understand price movements and trading levels that don't make sense given their earnings potential. \n\nFirst ever Reddit post, and first on this forum, so apologies if I haven't followed any prescribed format. . .", "created_utc": 1565210377, "permalink": "/r/wallstreetbets/comments/cnbbll/coherus_biosciences/", "is_self": true}